Background: Himalayan honey, a natural product of wild honey bees found in the Himalayan mountains of Nepal, has been used in medicine for many years. The successful development of nanotechnology and beneficial effects of honey would bring a new opportunity to synthesize hybrid nanomaterials for biomedical applications. Thus, the purpose of this study was to load Himalayan honey onto iron oxide nanoparticles (IO-NPs) and study their antioxidant and antimicrobial activities. Methods: Himalayan honey loaded iron oxide nanoparticles (HHLIO-NPs) were synthesized and X-ray diffraction (XRD) and scanning electron microscope (SEM) analyses were performed for characterization. UV-VIS spectra confirmed the loading of honey onto nanoparticles. The antioxidant activity of these nanoparticles was studied against 1, 1-diphenyl-2-picrylhydrazyl (DPPH) radical system. We also tested antimicrobial activity of HHLIO-NPs using well diffusion method towards both Gram-positive and Gram-negative bacterial strains of Staphylococus aureus & Escherichia coli. Results: From XRD analysis, the average particle size was found to be 33-40 nm. The SEM images show needle shape porous structures of HHLIO-NPs compared to free IO-NPs indicating the surfactant-like behaviour of honey. In DPPH radical system, the scavenging activities of Himalayan honey (HH), free IO-NPs and HHLIO-NPs ranged 7.93-35.99%, 11.02-52.02% and 16.10-80.52% respectively, with corresponding IC50 values of 1.36 mg/mL, 1.09 mg/mL and 0.52 mg/mL. The antimicrobial property of all test samples showed a noteworthy inhibition on both bacterial strains. However, the HH and HHLIO-NPs exhibited strong antibacterial activity against E. coli. Conclusion: This work reveals that the biological activity of HH is enhanced significantly after loading into IO-NPs. Thus, the HHLIO-NPs would be a promising alternative for antioxidant and antimicrobial agents.
Background: Himalayan honey, a natural product of wild honey bees found in the Himalayan mountains of Nepal, has been used in medicine for many years. The successful development of nanotechnology and beneficial effects of honey would bring a new opportunity to synthesize hybrid nanomaterials for biomedical applications. Thus, the purpose of this study was to load Himalayan honey onto iron oxide nanoparticles (IO-NPs) and study their antioxidant and antimicrobial activities. Methods: Himalayan honey loaded iron oxide nanoparticles (HHLIO-NPs) were synthesized and X-ray diffraction (XRD) and scanning electron microscope (SEM) analyses were performed for characterization. UV-VIS spectra confirmed the loading of honey onto nanoparticles. The antioxidant activity of these nanoparticles was studied against 1, 1-diphenyl-2-picrylhydrazyl (DPPH) radical system. We also tested antimicrobial activity of HHLIO-NPs using well diffusion method towards both Gram-positive and Gram-negative bacterial strains of Staphylococus aureus & Escherichia coli. Results: From XRD analysis, the average particle size was found to be 33-40 nm. The SEM images show needle shape porous structures of HHLIO-NPs compared to free IO-NPs indicating the surfactant-like behaviour of honey. In DPPH radical system, the scavenging activities of Himalayan honey (HH), free IO-NPs and HHLIO-NPs ranged 7.93-35.99%, 11.02-52.02% and 16.10-80.52% respectively, with corresponding IC50 values of 1.36 mg/mL, 1.09 mg/mL and 0.52 mg/mL. The antimicrobial property of all test samples showed a noteworthy inhibition on both bacterial strains. However, the HH and HHLIO-NPs exhibited strong antibacterial activity against E. coli. Conclusion: This work reveals that the biological activity of HH is enhanced significantly after loading into IO-NPs. Thus, the HHLIO-NPs would be a promising alternative for antioxidant and antimicrobial agents.
Oxidative stress is a state of disproportion in production of reactive molecules and active role of antioxidants, linked with various chronic diseases such as cancer, diabetes, neurodegenerative and cardiovascular diseases.1 Hence, natural products for their antioxidant properties have been screened in recent research activities using chemical and biological methods, or both.2 Several reports have advised that the continuous consumption of food with high antioxidants would decrease the incidence of various diseases.3 The presence of phenolic groups in chemical structure greatly contribute on the total effectiveness of antioxidants. Therefore, the natural metabolites with hydroxyl groups in aromatic ring are likely to show high antioxidant properties compared to synthetic ones used particularly in marketed food products. Although a number of natural products are considered as a main source of antioxidant agents, the investigation for naturally derived noble chemical compounds with good antioxidant properties is still a demanding field of science. Exploring the medicinal value of honey, which is a natural sweet food made by honey bees from plant nectars, would be one step forward for the search of new antioxidants as it has been consumed since ancient times for its health-boosting effects such as antibacterial, antioxidant, antiradical, anti-inflammatory, antimutagenic, anticarcinogenic, antiangiogenic, antiviral, anti-aging effects and stimulating agent for enzymes in the human body.4 These therapeutic effects of honey result from the presence of various phytoconstituents, including phenolic compounds, such as flavonoids and phenolic acids.5Natural product with nanotechnology is an emerging field as nanotechnology brings manifold advantages on natural drug delivery to cure chronic diseases. Furthermore, the natural product loaded nanoparticles can enhance the targeting, bioavailability, and controlled-release properties of natural drugs and their therapeutic values.6,7 In recent literature, there have been few articles published on natural product based nanotechnology.8 An essential oil, bergamot having in vitro anticancer properties when encapsulated into a nanoparticle using liposomes exhibited increased solubility of the drug with improved cell death.9 Furthermore, the bioavailability of a natural product, thymoquinone found in Nigella sativa, was increased sixfold after encapsulation in lipid nanocarriers when compared to free thymoquinone and prevents from gastrointestinal stuffs also .10 Some other studies have mentioned that the preparation and characterization of nanoparticles loaded with natural products such as curcumin, flavonoids and traditional Chinese medicines.11–15 Unlike other metallic analogus, iron oxide nanoparticles (IO-NPs) help to treat diseases and infections due to their notable biocompatible and magnetic properties.16 Therefore, the objective of this work was to load Himalayan honey into iron oxide nanoparticles and study their antioxidant and antimicrobial properties. The Himalayan honey collected from high altitude regions (2500–3500 masl) of Nepal was chosen for loading since it showed a significantly higher level of antioxidants than low altitude honey.17 The preparation of water soluble iron oxide nanoparticles and the action of honey loaded nanoparticles against free radicals and microbial strains are the center point of this research.The results from this research might be useful for effective design of natural product based nanoparticles and their application on protection, encapsulation and controlled release of bioactive molecules.
Material and methods
Honey sample collection
The Himalaya honey (HH) sample for research purposes was collected from the high altitude regions of Kaski district located in western Nepal where diverse medicinal plants are grown. The collected raw honey samples are made by Apis laboriosa species of honeybee and stored in refrigerator. The northern part of the districts slopes down from the Himalayan mountains of Machhapuchhre (6992 m), Annapurna I (8090 m) and Annapurna II (7937 m). The climate varies from subtropical, through temperate and subalpine, to alpine according to altitudes. The low altitude subtropical areas are warm for most of the year whilst the Himalayan Mountains in the north have a harsh cold climate.
Preparation of IO-NPs
Water soluble iron oxide nanoparticles (IO-NPs) were synthesized using method described by Wang et al.18 In this method, the mixture of 2 mmol FeCl3.2H2O (96.0%), 1 mmol of FeSO4.7H2O (99.0%) and 0.5 g of sodium citrate (99.0%) was ground with mortar. Then 0.32 g of NaOH (99.0%) was slowly added with constant crushing for about 10 minutes. Thereafter, the content was washed with distilled water followed by centrifugation (12,000 rpm) for 30 minutes. Then nanoparticles were separated by magnetic decantation and dried in open air. Thus prepared nanoparticles were characterized by X-ray diffraction (XRD), scanning electron microscope (SEM) and ultraviolet-visible (UV-VIS) spectroscopy analyses.
Loading of honey onto IO-NPs
Briefly, dried IO-NPs and HH (1:1) were mixed in 30 mL PBS. The mixture was maintained <4°C using an ice box and then stirred occasionally for 2 days. Finally, the Himalayan honey loaded IO-NPs (HHLIO-NPs) were obtained by magnetic decantation.19 The loading of honey onto IO-NPs was checked using UV-VIS and SEM analyses.
Antioxidant activity
The antioxidant activity studies of HH, IO-NPs and HHLIONPs were carried out using previously described 1,1–diphenyl-2-picrylhydrazyl radicals (DPPH) free radical assay.20,21 Briefly, stock solution of HHLIONPs (1 gm/mL) was used for serial dilutions (0.20, 0.35, 0.55, 0.70, 0.85 and 1.00 mg/mL). Then, 2 mL of DPPH solution (80 μg/mL in methanol) was added to 2 mL solution of each sample and absorbance was measured at 517 nm after reaction under dark for 30 minutes. Ascorbic acid (AA) dissolved in methanol (1 mg/mL) was used as reference standard. The control sample was included same volume of solvent and DPPH solution. For blank, 95% methanol was employed. The percent inhibition of DPPH free radical by HHLIO-NPs was measured using the following expression:where Ac was the absorbance of the control and As is the absorbance of the sample. The IC50 value (mg/mL), a minimum concentration of sample that inhibits 50% DPPH radical was also reported.
Antibacterial activity
The antibacterial activity of HH, IO-NPs and HHLIONPs were performed against bacterial strains of Staphylococcus aureus and Escherichia coli using agar well diffusion method.22 The agar plates were inoculated by uniform spreading of cotton swab dipped in bacterial culture and left for 15 minutes at 20±2°C in laminar chamber. Then five wells (7 mm diameter) on each plate were dug out using a cork borer and wells were treated with various concentrations of HH, IO-NPs and HHLIO-NPs followed by incubation at 37°C for 24 hours. The Amikacin (30 mg/disc) was used as positive control and wells treated with distilled water (D) worked as negative control. Zone of inhibition (mm) for each treatment was measured manually.
Results and discussion
Synthesis and characterization of honey loaded IO-NPs
First, IO-NPs were prepared from FeCl3.2H2O and FeSO4.7H2O by grinding in presence of sodium citrate as complexing agent and stabilizer to avoid particle aggregation.23,24 XRD and SEM analyses revealed the particle size. Furthermore, the loading of HH onto the IO-NPs was ascertained from the comparison of UV spectra obtained for loaded and free IO-NPs.The XRD pattern of IO-NPs (Figure 1) provided the particles size in between 30 and 40 nm using Scherrer’s equation. UV-VIS spectra of both free and HHLIO-NPs were compared to confirm the loading of honey onto nanoparticles. The same concentration of free and loaded IO-NPs was scanned for maximum absorbance. The spectra of free IO-NPs show absorption peak at 315 nm and HHLIONPs show similar absorption peaks with additional peaks at about 250–260 nm suggesting the loading of honey onto IO-NPs (Figure 2).
Figure 1
XRD pattern of iron oxide nanoparticles.
Abbreviation: XRD, X-ray diffraction.
Figure 2
UV spectra of Himalayan honey loaded iron oxide nanoparticle (HHLIO-NPs) and iron oxide nanoparticle (IO-NPs).
Abbreviations: HHLIO-NPs, Himalayan honey loaded iron oxide nanoparticles; IO-NPs, iron oxide nanoparticles; UV, ultraviolet.
XRD pattern of iron oxide nanoparticles.Abbreviation: XRD, X-ray diffraction.UV spectra of Himalayan honey loaded iron oxide nanoparticle (HHLIO-NPs) and iron oxide nanoparticle (IO-NPs).Abbreviations: HHLIO-NPs, Himalayan honey loaded iron oxide nanoparticles; IO-NPs, iron oxide nanoparticles; UV, ultraviolet.SEM images in Figure 3 revealed pronounced and needle shaped structures of HHLIO-NPs suggesting the role of honey as a surfactant. The spherical features in the images that are about 200 nm in diameter might be the residues from the honey itself.
Figure 3
SEM images (A) free iron oxide nanoparticles and (B) Himalayan honey loaded iron oxide nanoparticles. This illustrates the loading of honey on nanoparticles as suggested by the UV spectra.
Abbreviations: SEM, scanning electron microscope; UV, ultraviolet.
SEM images (A) free iron oxide nanoparticles and (B) Himalayan honey loaded iron oxide nanoparticles. This illustrates the loading of honey on nanoparticles as suggested by the UV spectra.Abbreviations: SEM, scanning electron microscope; UV, ultraviolet.
Antioxidant and antibacterial activities
The violet coloration of DPPH free electron in methanol was attributed due to wide spread of electron on whole molecule that prevents dimerization25 and therefore DPPH produces an intense absorption peak at 517 nm. The antioxidant activities of HH, IO-NPs and HHLIO-NPs with DPPH free radical was shown in Table 1. The results confirmed that the antioxidant activities of HH after being loaded onto IO-NPs increased in a dose-dependent manner by two-fold compared with honey alone. From Figure 4, it can be said that the absorption peaks of DPPH radical were reduced with the increasing concentration of test samples.
Table 1
Percent inhibition of DPPH radicals and IC50 values of HH, IO-NPs and HHLIO-NPs
Himalayan honey loaded iron oxide nanoparticles (HHLIO-NPs)
Concentration (mg/mL)
DPPH assay (% inhibition±SD)
IC50 (mg/mL)
0.20
16.10±4.32
0.52
0.35
30.99±3.23
0.55
53.08±6.02
0.70
59.91±3.12
0.85
66.77±5.14
1.00
80.52±4.13
Iron oxide nanoparticles (IO-NPs)
Concentration (mg/mL)
DPPH assay (% inhibition±SD)
IC50 (mg/mL)
0.20
11.02±2.54
1.09
0.35
20.78±4.61
0.55
27.56±3.05
0.70
31.23±5.12
0.85
34.67±4.36
1.00
52.02±3.76
Himalayan honey (HH)
Concentration (mg/mL)
DPPH assay (% inhibition±SD)
IC50 (mg/mL)
0.20
7.93±3.20
1.36
0.35
9.20±2.54
0.55
13.01±4.21
0.70
18.71±3.21
0.85
21.50±4.73
1.00
35.99±5.43
Abbreviations: DPPH, 1,1–diphenyl-2-picrylhydrazyl; HH, Himalayan honey; IO-NPs, iron oxide nanoparticles; HHLIO-NPs, Himalayan honey loaded iron oxide nanoparticles.
Figure 4
UV spectra showing dose-dependent free radical scavenging by (A) HH, (B) IO-NPs and (C) HHLIO-NPs.
Abbreviations: DPPH, 1,1–diphenyl-2-picrylhydrazyl; UV, ultraviolet; HH, Himalayan honey; IO-NPs, iron oxide nanoparticles; HHLIO-NPs, Himalayan honey loaded iron oxide nanoparticles.
Percent inhibition of DPPH radicals and IC50 values of HH, IO-NPs and HHLIO-NPsAbbreviations: DPPH, 1,1–diphenyl-2-picrylhydrazyl; HH, Himalayan honey; IO-NPs, iron oxide nanoparticles; HHLIO-NPs, Himalayan honey loaded iron oxide nanoparticles.UV spectra showing dose-dependent free radical scavenging by (A) HH, (B) IO-NPs and (C) HHLIO-NPs.Abbreviations: DPPH, 1,1–diphenyl-2-picrylhydrazyl; UV, ultraviolet; HH, Himalayan honey; IO-NPs, iron oxide nanoparticles; HHLIO-NPs, Himalayan honey loaded iron oxide nanoparticles.The antioxidant activity of HH can be related to the presence of antioxidants like phenolics and flavonoids.26,27 The Fe3O4 nanoparticles also significantly scavenged the free radicals showing good antioxidant activity. This property could be attributed to the electron transfer from the Fe+2/Fe+3 systems of IO-NPs. As a result, an enhanced radical scavenging of 80% was shown by HHLIO-NPs whereas 49% and 35% by free IO-NPs and HH respectively in 1 mg/mL concentration. In a study conducted by Bhattacharya, 3 mg/mL of Fe2O3/C nanocomposites showed 89% inhibition of DPPH radicals.28 A recent study also shows the radical scavenging of 40% by free IO-NPs at 1000 µg/mL.29 The present study showed that the HHLIO-NPs have greater antioxidant potential compared to other tested samples (Figure 5). The DPPH scavenging percent of HHLIO-NPs was rapidly increased from 16 to 80% for 0.20 and 1 mg/mL concentrations, respectively.
Figure 5
Changes in percentage of DPPH inhibition in HH, IONPs and HHLIONPs.
Abbreviations: DPPH, 1,1–diphenyl-2-picrylhydrazyl; HH, Himalayan honey; IO-NPs, iron oxide nanoparticles; HHLIO-NPs, Himalayan honey loaded iron oxide nanoparticles.
Changes in percentage of DPPH inhibition in HH, IONPs and HHLIONPs.Abbreviations: DPPH, 1,1–diphenyl-2-picrylhydrazyl; HH, Himalayan honey; IO-NPs, iron oxide nanoparticles; HHLIO-NPs, Himalayan honey loaded iron oxide nanoparticles.Table 1 shows IC50 values with respect to HH, IO-NPs and HHLIO-NPs are 1.36, 1.09 and 0.52 mg/mL respectively. Similar to our result, a recent study reported the IC50 value of IO-NPs as 1 mg/mL to scavenge ABTS (2, 2’-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid), a free radical similar to DPPH.30 In results from the other studies on the antioxidant activity of honey, IC50 values varied from 4.2 to 168.94 mg/mL.31,32 Compared to these facts, the honey used for this work has a higher antioxidant capacity. Figure 6 shows that the IC50 value of IO-NPs decreased twofold when HH was loaded into it. It was to be expected that the combined effort of HH and IO-NPs would neutralize the DPPH radicals.
Figure 6
Changes in IC50 values of HH, IO-NPs and HHLIO-NPs.
Abbreviations: HH, Himalayan honey; IO-NPs, iron oxide nanoparticles; HHLIO-NPs, Himalayan honey loaded iron oxide nanoparticles.
Changes in IC50 values of HH, IO-NPs and HHLIO-NPs.Abbreviations: HH, Himalayan honey; IO-NPs, iron oxide nanoparticles; HHLIO-NPs, Himalayan honey loaded iron oxide nanoparticles.The antibacterial activity of HH, IO-NPs and HHLIO-NPs against bacterial pathogens was studied (Figure 7 and Table 2). From the results, it is believed that HHLIO-NPs show significant activity over both tested bacterial strains with the zone of inhibition ranging from 6–18 mm (S. aureus) and 8–21 mm (E. coli) at 10 mg/mL and 100 mg/mL concentrations, respectively. The observed results on antibacterial activities for HHLIO-NP treatment are comparable to standard amikacin antibiotic with zones of inhibitions of 23 mm and 21 mm for S. aureus and E. coli, respectively. Such antibacterial activity of HHLIO-NPs might be due to combined effects of HH and IO-NPs. Figure 7 reveals that higher bacterial growth inhibition against E. coli than S. aureus was observed for each treatment. It is exciting to mention that the HH shows a zone of inhibition only against E. coli at low concentration (10 mg/mL) whereas IO-NPs did not show inhibition at the same concentration. This proves the high medicinal values of HH of Nepal. The bactericidal activity of honey is due to the presence of phytoconstituents whereas the effect of IO-NPs is because of smaller size.33,34
Figure 7
Zone of inhibition produced by HH (A), IO-NPs (B) and HHLIO-NPs (C) against both gram-positive and gram-negative bacterial stains.
Abbreviatons: HH, Himalayan honey; IO-NPs, iron oxide nanoparticles; HHLIO-NPs, Himalayan honey loaded iron oxide nanoparticles.
Table 2
Zone of inhibition (mm) measured for HH, IO-NPs and HHIO-NPs
Concentrations(mg/mL)
Strains
Escherichia coli
Staphylococcus aureus
HHLIO-NPs
10
8
6
40
15
13
70
18
17
100
21
18
IO-NPs
10
0
0
40
9
7
70
12
11
100
17
14
HH
10
7
5
40
13
12
70
15
13
100
19
16
Standard
30 (mg/disc)
21
23
Abbreviations: HH, Himalayan honey; IO-NPs, iron oxide nanoparticles; HHLIO-NPs, Himalayan honey loaded iron oxide nanoparticles.
Zone of inhibition (mm) measured for HH, IO-NPs and HHIO-NPsAbbreviations: HH, Himalayan honey; IO-NPs, iron oxide nanoparticles; HHLIO-NPs, Himalayan honey loaded iron oxide nanoparticles.Zone of inhibition produced by HH (A), IO-NPs (B) and HHLIO-NPs (C) against both gram-positive and gram-negative bacterial stains.Abbreviatons: HH, Himalayan honey; IO-NPs, iron oxide nanoparticles; HHLIO-NPs, Himalayan honey loaded iron oxide nanoparticles.Results from this work suggest that the gram-negative bacteria are more sensitive than gram-positive bacteria. In favor of our study, antibacterial activity of free IO-NPs and cotton fabric incorporated IO-NPs showed significant antibacterial activity against gram-negative bacteria, particularly E. coli in comparison with S. aureus.35 However, a study reported that the zone of inhibition of IO-NPs against S. aureus (gram-positive) was higher (20 mm) and lower (19 mm) for E. coli (gram-negative).36 A recent report has noted that the sample of Fe2O3.SnO2 nanoparticles synthesized with 0.008 M SDS produced significant antibacterial activity against gram-positive as well as gram-negative bacteria. It was mentioned that the SDS demonstrated activity against E. coli, B. subtilis and B. lichniformis with 0.75 cm, 0.8 cm and 0.725 cm zones of inhibitions respectively.37
Conclusion
In this work, HHLIO-NPs were synthesized by loading HH onto free IO-NPs and their antioxidant and antibacterial properties were studied. The antioxidant activity of HHLIO-NPs was increased twofold in comparison to HH alone. The antimicrobial activity against E. coli by all tested samples showed significant zone of inhibitions compared with S. aureus. Therefore, the HHLIO-NPs displayed notable synergistic effect on bacterial growth inhibition and free radical scavenging activity, and could be used as potential candidates for pharmaceutical and biomedical applications.
Authors: Soshan Cheong; Peter Ferguson; Kirk W Feindel; Ian F Hermans; Paul T Callaghan; Claire Meyer; Angela Slocombe; Chia-Hao Su; Fong-Yu Cheng; Chen-Sheng Yeh; Bridget Ingham; Michael F Toney; Richard D Tilley Journal: Angew Chem Int Ed Engl Date: 2011-04-06 Impact factor: 15.336
Authors: Maria da Conceição Tavares Cavalcanti Liberato; Selene Maia de Morais; Sônia Maria Costa Siqueira; Jane Eire Silva Alencar de Menezes; Denise Nogueira Ramos; Lyeghyna Karla Andrade Machado; Islay Lima Magalhães Journal: J Med Food Date: 2011-05-09 Impact factor: 2.786
Authors: A Barras; A Mezzetti; A Richard; S Lazzaroni; S Roux; P Melnyk; D Betbeder; N Monfilliette-Dupont Journal: Int J Pharm Date: 2009-06-06 Impact factor: 5.875